Protein Summary
Involved in transcriptional activation and repression of select genes by chromatin remodeling (alteration of DNA-nucleosome topology). Required for the stability of the SWI/SNF chromatin remodeling complex SWI/SNF-B (PBAF). Acts as a negative regulator of cell proliferation. This locus encodes a subunit of ATP-dependent chromatin-remodeling complexes. The encoded protein has been identified as in integral component of complexes necessary for ligand-dependent transcriptional activation by nuclear hormone receptors. Mutations at this locus have been associated with primary clear cell renal cell carcinoma. [provided by RefSeq, Feb 2012]
- ENST00000296302
- ENSP00000296302
- ENSG00000163939
- ENST00000337303
- ENSP00000338302
- ENST00000356770
- ENSP00000349213
- ENST00000394830
- ENSP00000378307
- ENST00000409057
- ENSP00000386593
- ENST00000409114
- ENSP00000386643
- ENST00000409767
- ENSP00000386601
- ENST00000410007
- ENSP00000386529
- ENST00000412587
- ENSP00000404579
- BAF180
- PB1
- PB1
- BAF180
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
interacting protein | 0.88 | ||
virus perturbation | 0.88 | ||
kinase perturbation | 0.81 | ||
microRNA | 0.76 | ||
transcription factor | 0.76 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 234.55 (req: < 5)
Gene RIFs: 80 (req: <= 3)
Antibodies: 152 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 234.55 (req: >= 5)
Gene RIFs: 80 (req: > 3)
Antibodies: 152 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 8
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 17
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drug: 0